The Indian Council of Medical Research (ICMR) has invited private companies and manufacturers to collaborate on the joint ...

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS® (brentuximab vedotin) in combination with ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...

Bristol Myers Squibb today announced new five-year results from the POETYK PSO long-term extension (LTE) trial of Sotyktu (deucravacitinib) treatment in adult patients with moderate-to-severe plaque ...

Recent studies reveal that the human appendix plays roles in gut microbiota restoration and immunity, contrary to its ...

Bristol Myers Squibb announces positive data from POETYK PSO LTE trial of Sotyktu to treat moderate-to-severe plaque psoriasis: Princeton, New Jersey Tuesday, February 18, 2025, 1 ...

ShareThe scene Miss OMG just couldn’t wait to hang out with BJ (her boyfriend of 6 weeks), excitedly they strolled and ...

Doctors explain why constant burping isn't just embarrassing - it could indicate serious digestive problems requiring medical ...

In Europe alone, approximately 2 million people live with chronic inflammatory bowel diseases (IBD), and their incidence has ...

A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...

Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...